-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OUS7HQG6XykoXFMEz1iRBTwU8qZgr5u6Bm2PhiNauYMe+k0ArECKDkXZLX1MeLfO dmstL/TT2lWbGPohRPQ2WQ== 0001193125-06-226027.txt : 20061107 0001193125-06-226027.hdr.sgml : 20061107 20061107083406 ACCESSION NUMBER: 0001193125-06-226027 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20061107 DATE AS OF CHANGE: 20061107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OSCIENT PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0000356830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042297484 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-128735 FILM NUMBER: 061192088 BUSINESS ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 7813982300 MAIL ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: GENOME THERAPEUTICS CORP DATE OF NAME CHANGE: 19941215 FORMER COMPANY: FORMER CONFORMED NAME: COLLABORATIVE RESEARCH INC DATE OF NAME CHANGE: 19920703 RW 1 drw.htm REQUEST FOR WITHDRAWAL Request for Withdrawal

OSCIENT PHARMACEUTICALS CORPORATION

1000 Winter Street

Suite 2200

Waltham, Massachusetts 02451

November 7, 2006

Securities and Exchange Commission

100 F. Street, N.E.

Washington, D.C. 20549

 

Re: Oscient Pharmaceuticals Corporation

Registration Statement on Form S-3

Filed with the Securities and Exchange Commission on September 30, 2005

(Registration No. 333-128735)

Request for Withdrawal

Ladies and Gentlemen:

Pursuant to Rule 477 promulgated under the Securities Act of 1933, Oscient Pharmaceuticals Corporation (the “Company”) hereby applies for the withdrawal of its registration statement on Form S-3, File No. 333-128735 which was filed on September 30, 2005 (the “Registration Statement”).

No sales of any of the Company’s securities have been completed pursuant to the Registration Statement. The Company filed a new shelf registration statement on Form S-3 with the Commission on September 26, 2006 that has become effective. As a result, the Company does not intend to sell securities registered pursuant to the Registration Statement.

Accordingly, the Company respectfully requests that the Commission grant an order for the withdrawal of the Registration Statement and declare the withdrawal effective as soon as possible.

Should you have any comments please contact the Company’s legal counsel, Patrick O’Brien at (617) 951–7257.

Very truly yours,

OSCIENT PHARMACEUTICALS CORPORATION

By: /s/ Philippe M. Maitre                            

        Philippe M. Maitre

        Senior Vice President and Chief Financial Officer

-----END PRIVACY-ENHANCED MESSAGE-----